Device type · EZW
Stimulator, Electrical, Implantable, For Incontinence
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
EZW
Gastroenterology & Urology
Device class
Class III
FDA decisions since 2015
3
510(k), De Novo and PMA
Adverse event reports
6,750
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Stimulator, Electrical, Implantable, For Incontinence
- Product code
- EZW
- Device class
- Class III
- Review panel
- Gastroenterology & Urology
- Regulation
- 21 CFR 876.5270
- FDA record
- Classification database entry for EZW
Latest FDA decisions
P240031 · Decided Jun 17, 2025 · 267 days after receipt
Device type: Stimulator, electrical, implantable, for incontinence (EZW) · GI, Urology & Nephrology
P170001 · Decided Jan 11, 2023 · 2,185 days after receipt
Device type: Stimulator, electrical, implantable, for incontinence (EZW) · GI, Urology & Nephrology
P180046 · Decided Nov 13, 2019 · 342 days after receipt
Device type: Stimulator, electrical, implantable, for incontinence (EZW) · GI, Urology & Nephrology
Reports received
6,750
Received Nov 1, 2025 to Nov 19, 2026. Includes 21 of another or unstated type.
Malfunction reports
2,602
39% of reports
Injury reports
4,127
61% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 196 | 206 | 1 | 0 |
| Jan 24 | 243 | 225 | 0 | 0 |
| Feb 24 | 225 | 221 | 0 | 0 |
| Mar 24 | 232 | 192 | 0 | 0 |
| Apr 24 | 221 | 213 | 0 | 0 |
| May 24 | 257 | 225 | 0 | 0 |
| Jun 24 | 227 | 205 | 0 | 0 |
| Jul 24 | 291 | 250 | 0 | 0 |
| Aug 24 | 348 | 233 | 0 | 0 |
| Sep 24 | 297 | 238 | 0 | 0 |
| Oct 24 | 282 | 295 | 1 | 0 |
| Nov 24 | 211 | 212 | 0 | 0 |
| Dec 24 | 216 | 213 | 0 | 0 |
| Jan 25 | 283 | 276 | 0 | 0 |
| Feb 25 | 296 | 234 | 0 | 0 |
| Mar 25 | 233 | 226 | 0 | 0 |
| Apr 25 | 362 | 275 | 0 | 0 |
| May 25 | 346 | 298 | 0 | 0 |
| Jun 25 | 252 | 340 | 0 | 0 |
| Jul 25 | 273 | 327 | 0 | 0 |
| Aug 25 | 240 | 314 | 0 | 0 |
| Sep 25 | 244 | 375 | 0 | 0 |
| Oct 25 | 306 | 436 | 1 | 0 |
| Nov 25 | 254 | 319 | 0 | 0 |
| Dec 25 | 254 | 282 | 0 | 0 |
| Jan 26 | 227 | 233 | 0 | 0 |
| Feb 26 | 257 | 262 | 0 | 0 |
| Mar 26 | 264 | 314 | 0 | 0 |
| Apr 26 | 262 | 273 | 0 | 0 |
| May 26 | 283 | 280 | 0 | 1 |
| Jun 26 | 282 | 262 | 0 | 0 |
| Jul 26 | 212 | 384 | 0 | 0 |
| Aug 26 | 110 | 483 | 0 | 7 |
| Sep 26 | 118 | 554 | 0 | 7 |
| Oct 26 | 79 | 481 | 0 | 6 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Insufficient Device Problem Information1,675
- Adverse Event Without Identified Device or Use Problem1,596
- Migration or Expulsion of Device791
- Failure to Deliver Energy597
- Communication or Transmission Problem581
- Inappropriate/Inadequate Shock/Stimulation553
- Energy Output Problem550
- Electromagnetic Compatibility Problem519
- Battery Problem395
- Unintended Collision372
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions2,342
- Insufficient Information1,776
- Pain1,242
- Incontinence713
- Discomfort672
- Electric Shock540
- Urinary Frequency / Polyuria503
- Urinary Retention445
- Inappropriate Device Stimulation of Tissue321
- Unspecified Infection313
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- InterStim Percutaneous Extensions EXT 3560022 ISTM II PERC 3560022 EXT 3560030 ISTM MICRO PERC 3560030Open, Classified
Z-0267-2027 · Started Sep 8, 2026 · Posted by FDA Oct 22, 2026
Reason given: Wrong lead or percutaneous extension selected. Use of an incompatible lead or percutaneous extension will prevent the system from working as intended and may result in delay of surgery or need for surgical replacement of the product.
Cause as FDA categorized it: Under Investigation by firm
- Enhanced Verify Evaluation Handset (CFN HH90130FA)Open, Classified
Z-1704-2025 · Started Apr 3, 2025 · Posted by FDA Apr 30, 2025
Reason given: Evaluation handsets may not be able to communicate with the neurostimulator due to handsets having a faster processing speed than prior handsets. An inability to connect may cause the therapy to stop being delivered and a system error will be displayed. Patient may experience return of underlying disease symptoms...
Cause as FDA categorized it: Device Design
- PNE Lead Implant Kit REF: 1701Open, Classified
Z-0198-2027 · Started Jul 15, 2024 · Posted by FDA Oct 16, 2026
Reason given: Retroactively Reported: 10mL luer lock syringes included in kit may leak , break or experience other issues that may pose a risk to users.
Cause as FDA categorized it: Component change control
Z-3073-2024 · Started Jun 17, 2024 · Posted by FDA Sep 6, 2024
Reason given: A subset of the handsets within the kit may not be able to complete the pairing process with the communicator upon initial setup.
Cause as FDA categorized it: Software change control
- Medtronic InterStim Ground Pad REF 041826Open, Classified
Z-2365-2023 · Started Jul 6, 2023 · Posted by FDA Aug 10, 2023
Reason given: Lot of InterStim Self-Adhesive Ground Pad is being recalled due to the product being labeled with the incorrect expiration date.
Cause as FDA categorized it: Under Investigation by firm
Z-0998-2022 · Started Feb 28, 2022 · Posted by FDA Apr 22, 2022
Reason given: There is a software anomaly with the InterStim X Clinician software application with results in the data entered in the Patient Information fields not e retained and a " Data Lost" notification being displayed.
Cause as FDA categorized it: Software Design Change
Z-0293-2022 · Started Nov 4, 2021
Reason given: The wireless rechargers (WR; WR9200 and WR9220; included in the Recharger Kits) become unresponsive if the charging steps, indicated in the Recharger Patient User Guide, are not followed.
Cause as FDA categorized it: Other
Z-1774-2019 · Started May 15, 2019 · Posted by FDA Jun 7, 2019
Reason given: There is a potential for an unexpected increase in stimulation during InterStim programming with the A10 Clinician Application (on Medtronic's smart programmer).
Cause as FDA categorized it: Software design
Showing the 8 newest of 11 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.